Clinical Trials Update: Oct 31, 2002
Leber's Hereditary Optic Neuropathy (LHON) Obsessive-Compulsive Disorders Vaccines
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch.
Leber's Hereditary Optic Neuropathy (LHON)
This study will investigate the safety and effectiveness of an eye drop in preventing or reducing vision loss caused by Leber's Hereditary Optic Neuropathy (LHON) in the second eye, once a person has suffered vision loss in the first eye. Research sites located throughout the United States and Canada.
This is a research study for people diagnosed with Obsessive-Compulsive Disorder (OCD) and on medication. Research site located in Atlanta, Georgia.
This research study will test participants' immune responses to a smallpox vaccine. Research site located in Rochester, New York.
Copyright 2002 Centerwatch. All rights reserved.